NASDAQ:SANA
Sana Biotechnology, Inc. Stock News
$8.73
+0.180 (+2.11%)
At Close: May 17, 2024
SEATTLE, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the U.S. Food and
Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 03'rd Jan 2024
SEATTLE, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webc
Preclinical data with SC262, a HIP-modified CD22-directed allogeneic CAR T cell, further support completed IND submission
SEATTLE, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the publication in
Sana Biotechnology to Present at November and December 2023 Investor Conferences
09:00am, Tuesday, 21'st Nov 2023
SEATTLE, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webc
Sana Biotechnology to Present at September 2023 Investor Conferences
04:05pm, Wednesday, 30'th Aug 2023
SEATTLE, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webc
Sana Biotechnology: Hypoimmune Platform Might Stealth Cells
10:09am, Sunday, 09'th Jul 2023
Results from the phase 1 study using SC291 for the treatment of patients with B-cell lymphomas are expected to be released later in 2023. It is said that the global B-cell lymphoma treatment market co
Sana Biotechnology to Present at June 2023 Investor Conferences
04:05pm, Wednesday, 31'st May 2023
SEATTLE, May 31, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webca
7 High-Potential Penny Stocks in the Biotech Sector
01:56pm, Thursday, 04'th May 2023
Most of the biggest biotech stocks on the market started off as unknown penny stocks. Look at Axsome Therapeutics (NASDAQ: AXSM ), for example.
Sana Biotechnology to Present at May 2023 Investor Conferences
04:05pm, Wednesday, 03'rd May 2023
SEATTLE, May 03, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webca
Wall Street Analysts Believe Sana (SANA) Could Rally 83.17%: Here's is How to Trade
11:27am, Wednesday, 03'rd May 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 83.2% in Sana (SANA). While the effectiveness of this highly sought-after metric is questionable, the positive
The Top 3 Biotech Stocks to Watch in 2023
10:07am, Thursday, 20'th Apr 2023
Investors may want to keep an eye on the biotech boom and these top biotech stocks to watch. For one, the sector is still one of the safest, most recession-proof investments around.
2 Growth Stocks That Jumped 42% and 58% Last Week: Can They Still Climb Higher?
06:17am, Monday, 17'th Apr 2023
The week that ended April 14 was a good one for markets overall and a great one for two stocks in the healthcare sector. Sana Biotechnology jumped 58% higher last week as investors cheered preclinical
Why Shares of Sana Biotechnology Jumped This Week
10:27am, Friday, 14'th Apr 2023
Sana Biotechnology is developing a cell-editing platform that it hopes will be able to avoid immune-system rejection. The company has no revenue but enough cash to fund operations into 2025, it said.
Sana Biotechnology to Present at the Cowen 43rd Annual Health Care Conference
04:05pm, Wednesday, 01'st Mar 2023
SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast i